| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 02/13/2013 | CN102933571A Phthalazin-(2h)-one inhibitors of kinases |
| 02/13/2013 | CN102933561A Pharmaceutically active disubstituted triazine derivatives |
| 02/13/2013 | CN102933556A N-[(het)arylethyl)] pyrazole(thio)carboxamides and their heterosubstituted analogues |
| 02/13/2013 | CN102933553A 7,11-methanocycloocta [b] quinoline derivative as highly functionalizable acetylcholinesterase inhibitors |
| 02/13/2013 | CN102933548A Carboxamide compounds and their use as calpain inhibitors |
| 02/13/2013 | CN102933214A 4,4-disubstituted piperidine derivatives useful as inhibitors of dipeptidyl peptidase-1 (dpp-1) |
| 02/13/2013 | CN102933205A Cilostazol cocrystals and compositions |
| 02/13/2013 | CN102924446A PIM kinase inhibitor, preparation method thereof, and application thereof in pharmacy |
| 02/13/2013 | CN102924445A PIM kinase inhibitor, preparation method thereof, and application thereof in pharmacy |
| 02/13/2013 | CN102924436A Refining method of fasudil hydrochloride |
| 02/13/2013 | CN102924435A Novel crystal form of S-omeprazole magnesium salt and preparing method thereof |
| 02/13/2013 | CN102924434A Dexrabeprazole sodium monohydrate crystal form and preparation method thereof |
| 02/13/2013 | CN102924433A Acetamido derivant including pyridine parazole formoxyl as well as preparing method and application thereof |
| 02/13/2013 | CN102924432A Preparation method of high-purity thalidomide |
| 02/13/2013 | CN102924431A Organic luminescent compound containing acridine core and application thereof in electroluminescent device |
| 02/13/2013 | CN102924430A Desloratadine derivatives, and preparation method and application thereof |
| 02/13/2013 | CN102093336B Method for extracting alkaloid by utilizing waste water and sludge of tobaccos |
| 02/13/2013 | CN101808999B Quinoline derivatives as 5HT5A receptor antagonists |
| 02/13/2013 | CN101528734B 3 -amino- pyridine derivatives for the treatment of metabolic disorders |
| 02/13/2013 | CN101490035B Amino-piperidine derivatives as CETP inhibitors |
| 02/13/2013 | CN101445469B Inhibitors of histone deacetylase |
| 02/13/2013 | CN101379057B Succinic acid salt of biphenyl-2-ylcarbamic acid 1-[2-(2-chloro-4-{[(R)-2-hydroxy-2- (8-hydroxy-2-oxo-1, 2-dihydroquinolin-5-yl) eth ylaminoimethyl]} -5-methoxyphenylcarbamoyl) ethyl]piperidin-4-yl es |
| 02/12/2013 | US8372981 Nitrogen-containing aromatic derivatives |
| 02/12/2013 | US8372973 Prokineticin 1 receptor antagonists |
| 02/12/2013 | US8372971 Heterocyclic compounds and methods of use |
| 02/12/2013 | US8372970 8-ethyl-6-(aryl)pyrido[2,3-D]pyrimidin-7(8H)-ones for the treatment of CNS disorders |
| 02/12/2013 | US8372867 Insecticidal aryl isoxazoline derivatives |
| 02/12/2013 | US8372849 Heterocyclic compounds |
| 02/12/2013 | US8372844 Piperazinyl-propyl-pyrazole derivatives as dopamine D4 receptor antagonists, and pharmaceutical compositions containing the same |
| 02/12/2013 | US8372841 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| 02/12/2013 | US8372837 Pyridone and pyridazone analogues as GPR119 modulators |
| 02/12/2013 | US8372836 Spray dried formulation |
| 02/12/2013 | CA2596527C Igf-1r inhibitors |
| 02/12/2013 | CA2574464C Substituted quinolones |
| 02/12/2013 | CA2480638C Substituted benzazoles and use thereof as raf kinase inhibitors |
| 02/07/2013 | WO2013019967A1 Modulators of virus assembly as antiviral agents |
| 02/07/2013 | WO2013019966A1 Aromatic bycyclic derivatives as cxcr4 receptor modulators |
| 02/07/2013 | WO2013019938A1 Pyridazine derivatives as eaat2 activators |
| 02/07/2013 | WO2013019561A1 Nuclear transport modulators and uses thereof |
| 02/07/2013 | WO2013019548A1 Hydrazide containing nuclear transport modulators and uses thereof |
| 02/07/2013 | WO2013018829A1 Method for treating cancer by combined use of medicinal agents |
| 02/07/2013 | WO2013018804A1 Uracil derivative and use thereof for medical purposes |
| 02/07/2013 | WO2013017657A1 Phenyl-3-aza-bicyclo[3.1.0]hex-3-yl-methanones and the use thereof as medicament |
| 02/07/2013 | WO2013017559A1 N-(tetrazol-5-yl)- and n-(triazol-5-yl)arylcarboxamides and use thereof as herbicides |
| 02/07/2013 | WO2013017461A1 Pyridin-2(1h)-one derivatives as jak inhibitors |
| 02/07/2013 | WO2010106551A3 A process for the manufacture of pure anhydrous aripiprazole form b |
| 02/07/2013 | US20130035491 1,2,4, 5-substituted phenyl compound, method for producing same and organic electroluminescent device comprising same as constituent |
| 02/07/2013 | US20130035480 Functionalization and purification of molecules by reversible group exchange |
| 02/07/2013 | US20130035354 Aryl pyridine as aldosterone synthase inhibitors |
| 02/07/2013 | US20130035351 Oximes For Treatment Of Peripheral And Central Nervous System Exposure To Acetyl Cholinesterase Inhibitors |
| 02/07/2013 | US20130035347 Aromatic bycyclic derivatives as cxcr4 receptor modulators |
| 02/07/2013 | US20130035342 Compound Suitable for the Treatment of Synucleopathies |
| 02/07/2013 | US20130035339 Apoptosis signal-regulating kinase inhibitors |
| 02/07/2013 | US20130035337 Fused bicyclic heteroaryl derivative |
| 02/07/2013 | US20130035329 Therapeutically active compositions and their methods of use |
| 02/07/2013 | US20130035327 Modulators of ATP-Binding Cassette Transporters |
| 02/07/2013 | US20130035326 Biaryl compounds and methods of use thereof |
| 02/07/2013 | US20130035312 Cathepsin cysteine protease inhibiors |
| 02/07/2013 | US20130034520 Hepatitis C Virus Inhibitors |
| 02/07/2013 | US20130034504 Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity |
| 02/07/2013 | US20130033416 Organic compound and organic light emitting device having the same |
| 02/07/2013 | US20130032788 Carbazole-based compound and organic light-emitting diode comprising the same |
| 02/07/2013 | US20130032787 Heterocyclic compound and organic light-emitting device including the same |
| 02/07/2013 | US20130032764 Materials for organic electroluminescence devices |
| 02/07/2013 | CA2844032A1 Method for treating cancer by combined use of drugs |
| 02/07/2013 | CA2843836A1 Uracil derivative and use thereof for medical purposes |
| 02/07/2013 | CA2843805A1 Phenyl-3-aza-bicyclo[3.1.0]hex-3-yl-methanones and the use thereof as medicament |
| 02/07/2013 | CA2842364A1 Nuclear transport modulators and uses thereof |
| 02/07/2013 | CA2842362A1 Hydrazide containing nuclear transport modulators and uses thereof |
| 02/07/2013 | CA2839805A1 Pyridin-2(1h)-one derivatives as jak inhibitors |
| 02/06/2013 | EP2554545A1 Carbazole-based compound and organic light-emitting diode comprising the same |
| 02/06/2013 | EP2554544A1 Pyridin-2(1h)-one derivatives as jak inhibitors |
| 02/06/2013 | EP2554541A1 Therapeutic agent or prophylactic agent for fibromyalgia |
| 02/06/2013 | EP2553019A1 Modified polymers for delivery of polynucleotides, method of manufacture, and methods of use thereof |
| 02/06/2013 | EP2552908A2 Heterocyclic compounds and their uses |
| 02/06/2013 | EP2552907A1 Pyridyltriazoles |
| 02/06/2013 | EP2552906A1 Cgrp receptor antagonist |
| 02/06/2013 | EP2552905A1 B-raf kinase inhibitors |
| 02/06/2013 | EP2552904A1 Process for the preparation of dexlansoprazole |
| 02/06/2013 | EP2552903A1 Salts of dexlansoprazole and their preparation |
| 02/06/2013 | EP2552902A1 Non-nucleoside reverse transcriptase inhibitors |
| 02/06/2013 | EP2552901A1 Preparation of hydrated polymorphs of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-quinolin-2-one lactic acid salt |
| 02/06/2013 | EP2552893A1 Antibacterial isoquinolin-3-ylurea derivatives |
| 02/06/2013 | EP2552888A1 "trpv1 vanilloid receptor antagonists with a bicyclic portion" |
| 02/06/2013 | EP2552886A1 Cytokine inhibitors |
| 02/06/2013 | EP2552214A1 Pyrazolyl-pyrimidines as kinase inhibitors |
| 02/06/2013 | EP2552209A1 Novel spiro imidazolone derivatives as glucagon receptor antagonists, compositions, and methods for their use |
| 02/06/2013 | EP2552208A1 Imidazolyl-imidazoles as kinase inhibitors |
| 02/06/2013 | CN1993327B 3-Carbamoyl-2-pyridone derivative |
| 02/06/2013 | CN102918037A Carbazole compound having substituent group including electron-accepting nitrogen-containing heteroaryl, and organic electroluminescent element |
| 02/06/2013 | CN102918036A 5-amino-3,6-dihydro-1h-pyrazin-2-one derivatives useful as inhibitors of beta-secretase (bace) |
| 02/06/2013 | CN102918035A 2 -amino- pyrimidine derivatives useful as inhibitors of jnk |
| 02/06/2013 | CN102918034A Multisubstituted aromatic compounds as inhibitors of thrombin |
| 02/06/2013 | CN102918031A Radiolabeled compounds and methods thereof |
| 02/06/2013 | CN102918027A Modulators of the gpr119 receptor and the treatment of disorders related thereto |
| 02/06/2013 | CN102912674A High-yield pulp yellowing inhibitor and preparation method and application thereof |
| 02/06/2013 | CN102911255A Preparation method of 18F marker containing 1,4-disubstituted triazole structure |
| 02/06/2013 | CN102911161A 病毒聚合酶抑制剂 Viral polymerase inhibitors |
| 02/06/2013 | CN102911160A Method for preparing and purifying dabigatran etexilate intermediate |
| 02/06/2013 | CN102911159A Carbazole-based compound and organic light-emitting diode comprising the same |